Announcements
- Denali Capital Acquisition Corp. Announces Shareholder Approval of Extension of Deadline to Complete Business Combination
- Correction: Denali Capital Acquisition Corp. and Longevity Biomedical, Inc. Mutually Agreed to Terminate the Business Combination
- Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination
Key statistics
On Wednesday, Denali Capital Acquisition Corp (193:FRA) closed at 10.00, -0.99% below its 52-week high of 10.10, set on Jul 02, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.00 |
---|---|
High | 0.00 |
Low | 0.00 |
Bid | -- |
Offer | -- |
Previous close | 10.00 |
Average volume | -- |
---|---|
Shares outstanding | 2.81m |
Free float | 744.32k |
P/E (TTM) | 54.19 |
Market cap | 32.28m USD |
EPS (TTM) | 0.2117 USD |
Data delayed at least 15 minutes, as of Jul 03 2024 08:59 BST.
More ▼